Uncategorized

Undervalued European Small Caps With Insider Action For May 2026

The European market has recently experienced modest gains, with the pan-European STOXX Europe 600 Index reflecting improved sentiment due to easing geopolitical tensions and strong corporate earnings, although concerns over potential U.S. tariffs loom. In this environment of fluctuating market dynamics, identifying small-cap stocks that are potentially undervalued can be crucial for investors seeking opportunities; these stocks often offer unique growth prospects when backed by solid fundamentals and strategic insider actions.

Top 10 Undervalued Small Caps With Insider Buying In Europe

Name

PE

PS

Discount to Fair Value

Value Rating

CellaVision

21.1x

3.9x

43.83%

★★★★★★

Eurocell

11.1x

0.3x

43.83%

★★★★★☆

Nederman Holding

16.4x

0.8x

33.21%

★★★★★☆

everplay group

7.4x

2.3x

5.80%

★★★★★☆

Embracer Group

3.5x

0.8x

25.41%

★★★★★☆

Bilia

15.5x

0.3x

43.84%

★★★★☆☆

Morgan Advanced Materials

NA

0.6x

38.00%

★★★★☆☆

Lemonsoft Oyj

18.8x

3.1x

36.91%

★★★★☆☆

Cloetta

20.5x

1.8x

28.37%

★★★☆☆☆

AB Dynamics

NA

2.2x

37.27%

★★★☆☆☆

Click here to see the full list of 88 stocks from our Undervalued European Small Caps With Insider Buying screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Simply Wall St Value Rating: ★★★★★★

Overview: AddLife is a company engaged in providing products and services within the Labtech and Medtech sectors, with a market cap of approximately SEK 14.12 billion.

Operations: The company generates revenue primarily from its Labtech and Medtech segments, with recent figures showing SEK 3949 million and SEK 6442 million, respectively. The gross profit margin has seen fluctuations, reaching up to 38.29% in early 2026. Operating expenses are substantial, driven mainly by sales and marketing costs. Over the years, net income margins have varied significantly, reflecting changes in non-operating expenses and other financial factors.

PE: 31.3x

AddLife, a European small cap, shows potential despite its high debt levels, relying solely on external borrowing. The company reported SEK 2,645 million in sales for Q1 2026 with net income of SEK 127 million. Earnings per share rose to SEK 1.04 from SEK 0.98 last year, reflecting solid earnings quality despite large one-off items impacting results. Insider confidence is evident with recent share purchases in April 2026, suggesting optimism about future growth prospects at a forecasted rate of nearly 15% annually.

OM:ALIF B Share price vs Value as at May 2026

Simply Wall St Value Rating: ★★★★★★

Source link

Visited 1 times, 1 visit(s) today

Leave a Reply

Your email address will not be published. Required fields are marked *